Merck signs $356 million U.S. supply deal for its experimental COVID-19 treatment

(Reuters) -Merck & Co said on Wednesday it would supply 60,000-100,000 doses of its experimental COVID-19 treatment to the U.S. government for up to about $356 million.

Reuters December 24, 2020 00:06:02 IST
Merck signs $356 million U.S. supply deal for its experimental COVID-19 treatment

Merck signs 356 million US supply deal for its experimental COVID19 treatment

(Reuters) -Merck & Co said on Wednesday it would supply 60,000-100,000 doses of its experimental COVID-19 treatment to the U.S. government for up to about $356 million.

The agreement will help support advanced development and large-scale manufacturing of the company's investigational therapeutic MK-7110 to treat hospitalized patients with severe or critical COVID-19, the U.S. Department of Health and Human Services said.

The funding allows for development of MK-7110, including completing activities required to request emergency use authorization from the U.S. Food and Drug Administration, and for delivery of the doses by June 30, 2021.

Merck has built out its portfolio of COVID-19 treatments through a series of deals in recent months, including the acquisition of drugmaker Themis and a partnership with Ridgeback Biotherapeutics LP.

The company in November agreed to buy OncoImmune in a $425 million deal that gave it control of MK-7110, a promising first-in-class fusion protein and immune modulator. Immune modulators have the potential to minimize the damaging effects of an overactive immune response to COVID-19.

Interim data from September showed that the therapy, which is administered as an injection, increased the likelihood of symptom improvement in serious COVID-19 cases and also reduced the risk of respiratory failure and death.

The doses will be made available to the American public at no cost, the agency said.

The United States has authorized two vaccine for emergency use this month and more than 600,000 Americans had received their first COVID-19 vaccine doses as of Monday, but the need for treatments for those hospitalized remain high.

Merck is also working on two potential vaccines that are still in early stages of development. It is also collaborating with Ridgeback in developing an antiviral treatment called molnupiravir.

The company's shares rose nearly 1% to $80 on Wednesday.

(Reporting by Ankur Banerjee in Bengaluru; Editing by Sriraj Kalluvila and Maju Samuel)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

also read

France, Germany to agree to NATO role against Islamic State - sources
| Reuters
World

France, Germany to agree to NATO role against Islamic State - sources | Reuters

By Robin Emmott and John Irish | BRUSSELS/PARIS BRUSSELS/PARIS France and Germany will agree to a U.S. plan for NATO to take a bigger role in the fight against Islamic militants at a meeting with President Donald Trump on Thursday, but insist the move is purely symbolic, four senior European diplomats said.The decision to allow the North Atlantic Treaty Organization to join the coalition against Islamic State in Syria and Iraq follows weeks of pressure on the two allies, who are wary of NATO confronting Russia in Syria and of alienating Arab countries who see NATO as pushing a pro-Western agenda."NATO as an institution will join the coalition," said one senior diplomat involved in the discussions. "The question is whether this just a symbolic gesture to the United States

China's Xi says navy should become world class
| Reuters
World

China's Xi says navy should become world class | Reuters

BEIJING Chinese President Xi Jinping on Wednesday called for greater efforts to make the country's navy a world class one, strong in operations on, below and above the surface, as it steps up its ability to project power far from its shores.China's navy has taken an increasingly prominent role in recent months, with a rising star admiral taking command, its first aircraft carrier sailing around self-ruled Taiwan and a new aircraft carrier launched last month.With President Donald Trump promising a US shipbuilding spree and unnerving Beijing with his unpredictable approach on hot button issues including Taiwan and the South and East China Seas, China is pushing to narrow the gap with the U.S. Navy.Inspecting navy headquarters, Xi said the navy should "aim for the top ranks in the world", the Defence Ministry said in a statement about his visit."Building a strong and modern navy is an important mark of a top ranking global military," the ministry paraphrased Xi as saying.